# Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19

> **NCT04346147** · PHASE2 · UNKNOWN · sponsor: **Hospital Universitario de Fuenlabrada** · enrollment: 168 (actual)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **DRUG:** Imatinib tablets
- **DRUG:** Baricitinib Oral Tablet
- **OTHER:** Supportive tratment

## Key facts

- **NCT ID:** NCT04346147
- **Lead sponsor:** Hospital Universitario de Fuenlabrada
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-07
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-09
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346147, "Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04346147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*